SilverCloud for Depression and Anxiety in Youth
This study is testing a program called SilverCloud, which is an app-based Cognitive Behavioral Therapy (CBT) program, to see how well it works for high school students with depression and anxiety. It's also looking at how easy it is to use in schools. You could be eligible if you are between 13 and 22 years old, enrolled in high school, and have a score of 10 or higher on a depression (PHQ-9) or anxiety (GAD-7) questionnaire. The study will measure changes in your depression and anxiety scores at the beginning and after 8 weeks. This study is currently recruiting 120 participants.
- Study design
- This is an interventional study with a planned enrollment of 120 participants. It is an open trial, meaning both participants and researchers will know which treatment is being received.
- What's involved
- The primary endpoints for this study are measured at baseline and Week 8. This suggests participation will involve assessments at these two time points.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints are measured at Baseline and Week 8, indicating a follow-up period of at least 8 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
SilverCloud as a School-Based Intervention for Vulnerable Youth
At a glance
Conditions
NCT06004414
Where you'd take part
This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Northwell Health School Mental Health Partnership sites
Glen Oaks, New Yorkno site contact published
Not yet recruiting
NYU Langone Health
Brooklyn, New Yorkno site contact published
Recruiting
Rutgers University
New Brunswick, New Jerseyno site contact published
Not yet recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Anna Van Meter, PhD · PRINCIPAL_INVESTIGATOR · NYU Langone Health
- Erum Nadeem, PhD · PRINCIPAL_INVESTIGATOR · Rutgers University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Patient Health Questionnaire-9 (PHQ-9) ScoreBaseline, Week 8
The PHQ-9 is a 9-item questionnaire assessing the degree of depression severity. Items are ranked on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0-27; higher scores indicate greater severity of depression.
- Change in General Anxiety Disorder-7 (GAD-7) ScoreBaseline, Week 8
The GAD-7 is a 7-item questionnaire assessing the degree of anxiety severity. Items are ranked on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0-21; higher scores indicate greater severity of anxiety.